512 related articles for article (PubMed ID: 23274471)
41. Selection of regulatory T cells in the thymus.
Hsieh CS; Lee HM; Lio CW
Nat Rev Immunol; 2012 Feb; 12(3):157-67. PubMed ID: 22322317
[TBL] [Abstract][Full Text] [Related]
42. CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.
Long SA; Buckner JH
J Immunol; 2011 Sep; 187(5):2061-6. PubMed ID: 21856944
[TBL] [Abstract][Full Text] [Related]
43. Immunoregulatory T cells: role and potential as a target in malignancy.
Beyer M; Schultze JL
Curr Oncol Rep; 2008 Mar; 10(2):130-6. PubMed ID: 18377826
[TBL] [Abstract][Full Text] [Related]
44. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.
Hsieh CS; Zheng Y; Liang Y; Fontenot JD; Rudensky AY
Nat Immunol; 2006 Apr; 7(4):401-10. PubMed ID: 16532000
[TBL] [Abstract][Full Text] [Related]
45. The inhibitory cytokine IL-35 contributes to regulatory T-cell function.
Collison LW; Workman CJ; Kuo TT; Boyd K; Wang Y; Vignali KM; Cross R; Sehy D; Blumberg RS; Vignali DA
Nature; 2007 Nov; 450(7169):566-9. PubMed ID: 18033300
[TBL] [Abstract][Full Text] [Related]
46. T(reg) stability: to be or not to be.
Overacre AE; Vignali DA
Curr Opin Immunol; 2016 Apr; 39():39-43. PubMed ID: 26774863
[TBL] [Abstract][Full Text] [Related]
47. TGFbeta1 deficiency does not affect the generation and maintenance of CD4+CD25+FOXP3+ putative Treg cells, but causes their numerical inadequacy and loss of regulatory function.
Bommireddy R; Babcock GF; Singh RR; Doetschman T
Clin Immunol; 2008 May; 127(2):206-13. PubMed ID: 18308639
[TBL] [Abstract][Full Text] [Related]
48. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.
Korn T; Reddy J; Gao W; Bettelli E; Awasthi A; Petersen TR; Bäckström BT; Sobel RA; Wucherpfennig KW; Strom TB; Oukka M; Kuchroo VK
Nat Med; 2007 Apr; 13(4):423-31. PubMed ID: 17384649
[TBL] [Abstract][Full Text] [Related]
49. Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
Marson A; Kretschmer K; Frampton GM; Jacobsen ES; Polansky JK; MacIsaac KD; Levine SS; Fraenkel E; von Boehmer H; Young RA
Nature; 2007 Feb; 445(7130):931-5. PubMed ID: 17237765
[TBL] [Abstract][Full Text] [Related]
50. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.
Takahashi R; Nishimoto S; Muto G; Sekiya T; Tamiya T; Kimura A; Morita R; Asakawa M; Chinen T; Yoshimura A
J Exp Med; 2011 Sep; 208(10):2055-67. PubMed ID: 21893603
[TBL] [Abstract][Full Text] [Related]
51. Taking regulatory T cells into medicine.
Sakaguchi S
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 34037676
[TBL] [Abstract][Full Text] [Related]
52. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
53. Few Foxp3⁺ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity.
Mayer CT; Ghorbani P; Kühl AA; Stüve P; Hegemann M; Berod L; Gershwin ME; Sparwasser T
Eur J Immunol; 2014 Oct; 44(10):2990-3002. PubMed ID: 25042334
[TBL] [Abstract][Full Text] [Related]
54. The role of regulatory T cells in multiple sclerosis.
Zozulya AL; Wiendl H
Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
[TBL] [Abstract][Full Text] [Related]
55. Targeting Treg cells in cancer immunotherapy.
Tanaka A; Sakaguchi S
Eur J Immunol; 2019 Aug; 49(8):1140-1146. PubMed ID: 31257581
[TBL] [Abstract][Full Text] [Related]
56. Natural regulatory T cells in autoimmunity.
Lourenço EV; La Cava A
Autoimmunity; 2011 Feb; 44(1):33-42. PubMed ID: 21091291
[TBL] [Abstract][Full Text] [Related]
57. Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis.
Lee K; Hwang S; Paik DJ; Kim WK; Kim JM; Youn J
Clin Exp Immunol; 2012 Oct; 170(1):66-76. PubMed ID: 22943202
[TBL] [Abstract][Full Text] [Related]
58. CD4+ regulatory cells as a potential immunotherapy.
Fehérvari Z; Sakaguchi S
Philos Trans R Soc Lond B Biol Sci; 2005 Sep; 360(1461):1647-61. PubMed ID: 16147529
[TBL] [Abstract][Full Text] [Related]
59. Novel Foxo1-dependent transcriptional programs control T(reg) cell function.
Ouyang W; Liao W; Luo CT; Yin N; Huse M; Kim MV; Peng M; Chan P; Ma Q; Mo Y; Meijer D; Zhao K; Rudensky AY; Atwal G; Zhang MQ; Li MO
Nature; 2012 Nov; 491(7425):554-9. PubMed ID: 23135404
[TBL] [Abstract][Full Text] [Related]
60. Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation.
Sanders JM; Jeyamogan S; Mathew JM; Leventhal JR
Front Immunol; 2022; 13():1055466. PubMed ID: 36466912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
